ATE345782T1 - Dosierungsformen enthaltend geschmacksmaskierten wirkstoffen - Google Patents

Dosierungsformen enthaltend geschmacksmaskierten wirkstoffen

Info

Publication number
ATE345782T1
ATE345782T1 AT99971312T AT99971312T ATE345782T1 AT E345782 T1 ATE345782 T1 AT E345782T1 AT 99971312 T AT99971312 T AT 99971312T AT 99971312 T AT99971312 T AT 99971312T AT E345782 T1 ATE345782 T1 AT E345782T1
Authority
AT
Austria
Prior art keywords
dosage forms
active ingredients
forms containing
containing flavor
masked active
Prior art date
Application number
AT99971312T
Other languages
English (en)
Inventor
Djelila Mezaache
Michael G Raiden
Pradeepkumar P Sanghvi
Scott J Szedlock
Original Assignee
Biovail Tech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovail Tech Ltd filed Critical Biovail Tech Ltd
Application granted granted Critical
Publication of ATE345782T1 publication Critical patent/ATE345782T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99971312T 1998-10-30 1999-10-26 Dosierungsformen enthaltend geschmacksmaskierten wirkstoffen ATE345782T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/183,501 US6165512A (en) 1998-10-30 1998-10-30 Dosage forms containing taste masked active agents

Publications (1)

Publication Number Publication Date
ATE345782T1 true ATE345782T1 (de) 2006-12-15

Family

ID=22673073

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99971312T ATE345782T1 (de) 1998-10-30 1999-10-26 Dosierungsformen enthaltend geschmacksmaskierten wirkstoffen

Country Status (8)

Country Link
US (1) US6165512A (de)
EP (1) EP1124540B1 (de)
AT (1) ATE345782T1 (de)
AU (1) AU1232600A (de)
CA (1) CA2348451C (de)
DE (1) DE69934135T2 (de)
ES (1) ES2278466T3 (de)
WO (1) WO2000025755A1 (de)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057139A (en) 1995-06-29 2000-05-02 Mcneil-Ppc, Inc. Preblend of microcrystalline cellulose and lactase for making tablets
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
CA2348452A1 (en) * 1998-10-27 2000-05-04 Biovail Technologies Ltd. Microparticles containing peg and/or peg glyceryl esters
DK1179342T3 (da) * 1999-05-21 2006-07-31 Kissei Pharmaceutical Medicinske sammensætninger til öjeblikkelig frigivelse ved oral anvendelse
DE19940740A1 (de) * 1999-08-31 2001-03-01 Gruenenthal Gmbh Pharmazeutische Salze
CN100456962C (zh) * 2001-02-09 2009-02-04 荷兰联合利华有限公司 含大豆蛋白和抑制素的食物制品
WO2002074238A2 (en) * 2001-02-16 2002-09-26 Lavipharm Laboratories Inc. Water soluble and palatable complexes
CN1335182A (zh) * 2001-08-08 2002-02-13 华中科技大学 胰岛素口腔喷剂及其制备工艺
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US7323192B2 (en) 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
MXPA04002973A (es) 2001-09-28 2005-06-20 Johnson & Johnson Formas de dosis de liberacion modificada.
US6982094B2 (en) 2001-09-28 2006-01-03 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
EP1941878A1 (de) 2002-01-10 2008-07-09 Biovail Laboratories International Srl Sedative Formulierungen ohne Benzodiazepin
US20040034102A1 (en) * 2002-02-06 2004-02-19 King Pharmaceuticals, Inc. Oral pediatric trimethobenzamide formulations and methods
US20070087981A1 (en) * 2002-02-08 2007-04-19 Lavipharm Laboratories, Inc. Water Soluble and Palatable Complexes
US7807197B2 (en) 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
US6689343B1 (en) * 2002-11-05 2004-02-10 Ultradent Products, Inc. Hemostatic and acid etch compositions containing sucralose
US7282217B1 (en) 2003-08-29 2007-10-16 Kv Pharmaceutical Company Rapidly disintegrable tablets
RU2331410C2 (ru) 2003-12-04 2008-08-20 Пфайзер Продактс Инк. Способ получения фармацевтических мультичастиц
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
JP2007513147A (ja) 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク 押し出し機を使用して、好ましくはポロキサマーとグリセリドを含有する多粒子結晶性医薬組成物を製造するための噴霧凝結方法
US6984403B2 (en) 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
WO2005053651A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
US20050136112A1 (en) * 2003-12-19 2005-06-23 Pediamed Pharmaceuticals, Inc. Oral medicament delivery system
GB0400452D0 (en) * 2004-01-09 2004-02-11 Norton Healthcare Ltd A pharmaceutical composition
EP1621187A1 (de) * 2004-07-26 2006-02-01 AstraZeneca AB Pharmazeutische multipartikuläre Tablettenzubereitungen und Prozess zu ihrer Herstellung
US20060039966A1 (en) * 2004-08-12 2006-02-23 Miller Bruce A Jr Dosage delivery apparatus for improving user acceptance of oral supplements and medicaments and methods for manufacturing same
EP1640401A3 (de) * 2004-09-24 2006-04-12 Clariant Produkte (Deutschland) GmbH Polyethylenglykol und Alkoholethoxylate und deren Herstellung
US7611695B2 (en) * 2004-11-15 2009-11-03 Ultradent Products, Inc. Flavored hemostatic and acid etching compositions
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
PL2486942T3 (pl) 2004-11-24 2019-05-31 Meda Pharmaceuticals Inc Kompozycje zawierające azelastynę oraz sposoby ich stosowania
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
US20070134277A1 (en) * 2005-12-09 2007-06-14 Children's Medical Center Corporation Pharmaceutical formulation for sulfur-containing drugs in liquid dosage forms
EP1935405A1 (de) * 2006-12-22 2008-06-25 LEK Pharmaceuticals D.D. Im Mund zerfallende Tabletten
CA2677076C (en) * 2007-03-02 2017-09-12 Meda Pharmaceuticals Inc. Compositions comprising carisoprodol and methods of use thereof
EP2389155A2 (de) * 2009-01-16 2011-11-30 ADD Technologies Ltd. Im mund zerfallende tabletten zur behandlung von schmerzen
US8952038B2 (en) 2010-03-26 2015-02-10 Philip Morris Usa Inc. Inhibition of undesired sensory effects by the compound camphor
MX350636B (es) 2010-03-26 2017-09-12 Philip Morris Products Sa Inhibicion de irritacion sensorial durante el consumo de productos de tabaco no fumables.
US10561621B2 (en) 2010-09-20 2020-02-18 Diane Goll Microencapsulation process and product
FI126168B (en) * 2012-09-18 2016-07-29 Novaldmedical Ltd Oy A method for coating pharmaceutical substrates
US9662345B2 (en) 2013-06-14 2017-05-30 Professional Compounding Centers Of America Antibiotic composition for inhalation and irrigation
EP3061501A1 (de) 2015-02-27 2016-08-31 Rottapharm Ltd. Zusammensetzung zur behandlung von akne
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
EP3302104B1 (de) * 2015-06-04 2020-09-30 Balchem Corporation Hydrierungssteuerung für cholinsalze
PT3319596T (pt) * 2015-07-09 2024-01-17 Uniwell Laboratories Llc Composições farmacêuticas
EP3117825A1 (de) 2015-07-16 2017-01-18 Rottapharm S.p.A. Orale formulierung mit berberin und morus-alba-extrakt
CN108431152A (zh) * 2015-10-02 2018-08-21 帝斯曼知识产权资产管理有限公司 新颖的包衣体系
EP3419659A1 (de) 2016-02-23 2019-01-02 The Regents of the University of Colorado, A Body Corporate Zusammensetzungen und verfahren zur herstellung und verwendung thermostabiler immunogener formulierungen mit erhöhter kompatibilität der verwendung als impfstoffe gegen ein oder mehrere pathogene
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
WO2019143744A1 (en) 2018-01-16 2019-07-25 Applied Materials, Inc. Metal oxide encapsulated drug compositions and methods of preparing the same
KR20220051250A (ko) 2019-08-27 2022-04-26 어플라이드 머티어리얼스, 인코포레이티드 약제 남용 억제 제형들을 위한 증기상 코팅 기술
TW202122111A (zh) 2019-08-27 2021-06-16 美商應用材料股份有限公司 用於藥物溶解度控制之氣相塗層
TWI870622B (zh) 2020-10-02 2025-01-21 美商應用材料股份有限公司 製備氧化矽塗佈藥品的低溫處理
WO2023056304A1 (en) 2021-09-30 2023-04-06 Applied Materials, Inc. Low temperature silicon oxide coating for pharmaceutical applications

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5387431A (en) * 1991-10-25 1995-02-07 Fuisz Technologies Ltd. Saccharide-based matrix
EP0353045B1 (de) * 1988-07-26 1995-11-15 Rutgers, The State University of New Jersey Vorrichtungen und Verfahren zur Wachstumsförderung bei Bratgeflügel
EP0559897B1 (de) * 1990-11-30 1998-03-04 Yamanouchi Pharmaceutical Co. Ltd. Überdeckte zusammensetzung mit schneller freisetzung
CA2095776C (en) * 1992-05-12 2007-07-10 Richard C. Fuisz Rapidly dispersable compositions containing polydextrose
US5895664A (en) * 1993-09-10 1999-04-20 Fuisz Technologies Ltd. Process for forming quickly dispersing comestible unit and product therefrom
US5518551A (en) * 1993-09-10 1996-05-21 Fuisz Technologies Ltd. Spheroidal crystal sugar and method of making
EP0764019B1 (de) * 1994-06-14 2002-08-07 Biovail Technologies Ltd. Verfahren und apparat zur herstellung von schnelllöslichen dosierungseinheiten und daraus erhältliches produkt
US5683720A (en) * 1994-10-28 1997-11-04 Fuisz Technologies Ltd. Liquiflash particles and method of making same
US5458823A (en) * 1994-10-28 1995-10-17 Fuisz Technologies Ltd. Method and apparatus for spinning feedstock material
US5834033A (en) * 1997-05-12 1998-11-10 Fuisz Technologies Ltd. Apparatus for melt spinning feedstock material having a flow restricting ring
US5851454A (en) * 1997-06-13 1998-12-22 Fuisz Technologies, Ltd. Spinner head having flow restricting inserts
US5869098A (en) * 1997-08-20 1999-02-09 Fuisz Technologies Ltd. Fast-dissolving comestible units formed under high-speed/high-pressure conditions

Also Published As

Publication number Publication date
DE69934135D1 (de) 2007-01-04
DE69934135T2 (de) 2007-07-26
CA2348451C (en) 2009-01-27
ES2278466T3 (es) 2007-08-01
EP1124540B1 (de) 2006-11-22
CA2348451A1 (en) 2000-05-11
EP1124540A1 (de) 2001-08-22
US6165512A (en) 2000-12-26
WO2000025755A1 (en) 2000-05-11
AU1232600A (en) 2000-05-22

Similar Documents

Publication Publication Date Title
DE69934135D1 (de) Dosierungsformen enthaltend geschmacksmaskierten wirkstoffen
AR026745A1 (es) Composiciones de eplerenona nanoparticulada
UA42061C2 (uk) Фармацевтична композиція для перорального введення, що містить інгібітори протонного насоса
TR200001810A3 (tr) Hemen Eriyen Oral Dozaj Formülasyonu.
HUP0301349A2 (hu) IL-11-tartalmú készítmények
WO2005030141A3 (en) Morinda citrifolia-based oral care compositions and methods
MY125651A (en) Eplerenone compositions
DE69936393D1 (de) Behandlung akuter gesundheitsstörungen durch die sublingual verabreichung einer pharmazeutischen zusammensetzung
DE60120648D1 (de) Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung
TR200100172T2 (tr) Oral katı doz formunda eprosartan içeren biyolojik bakımdan kuvvetlendirilmiş formülasyonlar
MXPA05007643A (es) Metodo para producir una forma farmaceutica oral con desintegracion inmediata y liberacion de ingrediente activo.
NZ331705A (en) Immediate release ph-independent solid dosage form of cisapride
SE0102843D0 (sv) Stabilized oral pharmaceutical composition containing lodide and lodate and method
EP1123696A4 (de) Zubereitungen für die mundhöhle
IL141236A0 (en) New oral formulations for 5-ht4 agonists or antagonists
ATE215817T1 (de) Feste miltefosin enthaltende arzneimittel zur oralen verabreichung bei der behandlung von leishmaniasis
ATE370724T1 (de) Mundpflegemittel enthaltend einen fluor-ion- vektor und ein antioxidationsmittel
TNSN96016A1 (fr) Utilisation de phenylcyclohexylcarboxamides
WO1999047172A3 (en) Oral pharmaceutical compositions to be taken without liquids, which contain inclusion complexes
WO2000066070A3 (de) Verwendung nanoskaliger antimikrobieller wirkstoffe in der mund- und/oder zahnpflege
AU6524298A (en) Pharmaceutical composition, containing medium-chain fatty acids as active ingredients, for dental caries and periodontal disease
IT1297233B1 (it) Composizioni farmaceutiche solide in forma di caramelle contenenti disinfettanti e sostanze mucoadesive per una disinfezione topica
RU2007147328A (ru) Ускоритель рекальцинирования зубной эмали и композиция для ухода за полостью рта, и содержащие его пищевой продукт или напиток
TR200100863T2 (tr) (2S,3S,5R)-2-(3,5-Diflorofenil)-3,5-dimetil-2-morfolinol ve etkili dengeleyici miktarda alginik asit içeren oral dozaj formülasyonları.
MY152490A (en) New oral formulation

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties